COMMUNIQUÉS West-GlobeNewswire

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
12/06/2017
FIT Biotech Oy Company release June 12, 2017 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]
Zealand to regain control of elsiglutide
12/06/2017
Zealand to regain control of elsiglutide Helsinn returns elsiglutide to Zealand Zealand now has full rights to develop products within cancer-supportive care Lugano, Switzerland and Copenhagen, Denmark, June 12, 2017 - [...]
Herantis Pharma's clinical study with CDNF in Parkinson's disease authorized in Finland, company expands on development plan
12/06/2017
Herantis Pharma's clinical study with CDNF in Parkinson's disease authorized in Finland, company expands on development plan Herantis Pharma Plc Company release 12 June 2017 at 9:00 am Finnish Medicines Agency Fimea has [...]
Immunicum AB (publ) Announces Approval of the International Nonproprietary Name (INN) ilixadencel for INTUVAX®
12/06/2017
Press Release 12 June 2017 Immunicum AB (publ) Announces Approval of the International Nonproprietary Name (INN) ilixadencel for INTUVAX® --New Designation is One of the First Cell-based Therapy Names Established by the [...]
Basilea announces clinical study agreement with Adult Brain Tumor Consortium to explore BAL101553 in newly diagnosed glioblastoma
12/06/2017
The Adult Brain Tumor Consortium (ABTC) is designed to develop more effective treatments for malignant brain tumors. It is funded by the US National Cancer Institute (NCI). The ABTC will conduct a clinical phase 1 study [...]
TiGenix announces final equity payment for cardiac platform acquisition
12/06/2017
PRESS R ELEASE regulated information Leuven (BELGIUM) - June 12, 2017, 07:00h CEST - TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical company focused on exploiting the anti-inflammatory [...]
TiGenix annonce le paiement final en actions pour l'acquisition de sa plateforme cardiaque
12/06/2017
Communiqué de Presse Information réglementée Louvain (BELGIQUE) - 12 juin 2017, 7:00 h CEST - TiGenix NV (Euronext Brussels et NASDAQ: TIG), une société biopharmaceutique de pointe spécialisée dans l'exploration de [...]
Probiodrug announces encouraging results of the Phase 2a SAPHIR Study
11/06/2017
Probiodrug announces encouraging results of the Phase 2a SAPHIR Study HALLE (SAALE), Germany, 11 June 2017 - Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to [...]
Sanofi and Regeneron Announce Positive Results from First Dedicated Studies Evaluating Praluent® (alirocumab) in Individuals with Diabetes and Hypercholesterolemia
11/06/2017
Sanofi and Regeneron Announce Positive Results from First Dedicated Studies Evaluating Praluent ® (alirocumab) in Individuals with Diabetes and Hypercholesterolemia - Data presented at the 77 th Scientific Sessions of [...]
Sanofi et Regeneron annoncent les résultats positifs des premières études consacrées à l'évaluation de Praluent® (alirocumab) chez des personnes présentant un diabète et une hypercholestérolémie
11/06/2017
Sanofi et Regeneron annoncent les résultats positifs des premières études consacrées à l'évaluation de Praluent ® (alirocumab) chez des personnes présentant un diabète et une hypercholestérolémie - Les données de ces [...]
New analysis shows Soliqua® 100/33 lowered HbA1c by more than 2% in patients with screening levels greater than 9%
10/06/2017
Pressrelease - No. 6/2017 New analysis shows Soliqua ® 100/33 lowered HbA 1c by more than 2% in patients with screening levels greater than 9% All subgroups treated with Soliqua ® 100/33 achieved a mean HbA 1c of less [...]
Dasiglucagon (pINN) presentation at the 77th Scientific Sessions of the American Diabetes Association (ADA) indicate use for treatment of severe hypoglycemia
10/06/2017
Press Release - No. 5/2017 Dasiglucagon (pINN) presentation at the 77th Scientific Sessions of the American Diabetes Association (ADA) indicate use for treatment of severe hypoglycemia Elaborated results from Phase 2 [...]
XBiotech Announces Discontinuation of Phase III Study for Colorectal Cancer Based on Second Interim Analysis
09/06/2017
AUSTIN, Texas, June 09, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today that an Independent Data Monitoring Committee (IDMC) has performed its second prospectively planned, unblinded analysis of the [...]
Medable Launches Synapse, a Fully Integrated Clinical Care App Platform Using CareKit
09/06/2017
Medable's next generation disease management solution seeks to significantly improve health outcomes through provider and patient directed apps that track and trend patient health in real-time PALO ALTO, Calif., June 09 [...]
Medable lance Synapse, une plateforme d'application de soins cliniques intégralement intégrée utilisant CareKit
09/06/2017
La solution de gestion des maladies de la prochaine génération de Medable vise à améliorer significativement les résultats en matière de santé grâce à des applications destinées aux prestataires de soins et aux patients [...]
Publication of Idorsia's prospectus relating to the listing of Idorsia Ltd on SIX Swiss Exchange
09/06/2017
ALLSCHWIL/BASEL, SWITZERLAND - 09 June 2017 - Actelion Ltd (SIX:ATLN) today published the listing prospectus relating to the listing of Idorsia shares on SIX Swiss Exchange. With the tender offer for all publicly held [...]
Johnson & Johnson announces expected settlement of Actelion tender offer on June 16, 2017
09/06/2017
Announces receipt of all regulatory approvals required to complete acquisition of Actelion ALLSCHWIL/BASEL, SWITZERLAND - 09 June 2017 - Johnson & Johnson (NYSE:JNJ) today announced that, with today's receipt of [...]
Targovax ASA: Notice of Extraordinary General Meeting
09/06/2017
An Extraordinary General Meeting of Targovax ASA will be held at the Company's offices at Lysaker, on 30 June 2017 at 09:00 CET. Please find the notice including agenda for the Extraordinary General Meeting and [...]
Sixth Annual HOOPP LEAP Awards Honours Property Managers and Tenants for Outstanding Performance, Collaboration and Innovation
09/06/2017
TORONTO, June 09, 2017 (GLOBE NEWSWIRE) -- The Healthcare of Ontario Pension Plan (HOOPP) once again reinforced its role as a global leader in real estate sustainability practices by honouring property managers and [...]

Pages